Special CallCompany ParticipantsGuido Oelkers - CEO & PresidentMatthew WinfieldConference Call ParticipantsHerbert S.

The FDA has accepted for review the BLA for nanoencapsulated sirolimus plus pegadricase in the treatment of uncontrolled gout.

ABP-745 Phase II Trial Enrollment: Atom Therapeutics has enrolled the first patient in a global Phase II study of ABP-745, a ...

Atom has enrolled the first patient in a multi-country Phase 2 trial of ABP-745 for treatment of painful acute gout flares.

Medically reviewed by Barbie Cervoni, RD Cherries are packed with vitamin C, antioxidants, and anti-inflammatory compounds.Tart cherries may reduce inflammation and gout risk, while sweet cherries can ...

A retired Exeter banker is pushing body and mind to the limit by running 200 marathons in 200 days around Britain’s coastline ...

Patients who use NSAIDs for paradoxical gout flare prevention when starting allopurinol demonstrate greater risk for adverse ...

Many mistake gout for arthritis, delaying proper treatment and worsening the condition. Gout, caused by uric acid crystal ...

Gout, a painful arthritis caused by uric acid buildup, triggers flare-ups worsened by genetics, diet, alcohol, or medication.

Stockholm, Sweden Thursday, September 11, 2025, 11:00 Hrs [IST] ...

Steve James is striving to become the first man over the age of 60 to run the entire coastline of mainland Britain is due to reach Wales ...

Submission includes results of the pivotal DISSOLVE I and II studiesNASP PDUFA date set for 27 June 2026STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), a global biopharmaceutical ...